CAU
SBRA icon

Caxton Associates (UK)’s Sabra Healthcare REIT SBRA Stock Holding History

Caxton Associates (UK)’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.24M Sell
166,210
-5,173
-3% -$103K 0.06% 150
2026
Q1 		$3.3M Sell
171,383
-10,616
-6% -$209K 0.07% 119
2025
Q4 		$3.45M Buy
181,999
+69,199
+61% +$1.28M 0.07% 104
2025
Q3 		$2.1M Buy
112,800
+15,633
+16% +$292K 0.05% 188
2025
Q2 		$1.79M Sell
97,167
-7,936
-8% -$141K 0.05% 206
2025
Q1 		$1.84M Buy
+105,103
New +$1.77M 0.06% 176

Other funds holding SBRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Caxton Associates (UK)'s SBRA Position: Q2 2026 in Review

Caxton Associates (UK) reduced its Sabra Healthcare REIT (SBRA) stake by 3% in Q2 2026, selling an estimated $103K and leaving 166,210 shares worth $3.24M. The position accounts for 0.06% of the portfolio, ranked #150.

Caxton Associates (UK) first reported a position in SBRA in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.45M in Q4 2025. 463 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Caxton Associates (UK) held 166,210 shares of Sabra Healthcare REIT worth $3.24M as of Q2 2026.
  • Caxton Associates (UK) sold 5,173 Sabra Healthcare REIT shares in Q2 2026, an estimated $103K.
  • Sabra Healthcare REIT made up 0.06% of Caxton Associates (UK)'s portfolio in Q2 2026, its #150 holding.
  • Caxton Associates (UK) first reported a position in Sabra Healthcare REIT in Q1 2025 and has held it in 6 quarters since.
  • Caxton Associates (UK)'s Sabra Healthcare REIT position peaked at $3.45M in Q4 2025.
  • 463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.